Mitozantrone and methotrexate chemotherapy with and without mitomycin C in the treatment of advanced breast cancer: a randomised clinical trial
- 31 December 1992
- journal article
- clinical trial
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 28 (12), 1963-1965
- https://doi.org/10.1016/0959-8049(92)90237-v
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancerBritish Journal of Cancer, 1991
- A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancerBritish Journal of Cancer, 1991
- Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study)British Journal of Cancer, 1991
- Primary medical therapy for operable breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Reporting results of cancer treatmentCancer, 1981
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977